| Southern Kentucky Primary Care, P.s.c. | |
|
101 W 2nd St Russellville KY 42276 | |
| (270) 881-1813 | |
| (270) 886-6600 |
| Full Name | Southern Kentucky Primary Care, P.s.c. |
|---|---|
| Speciality | Clinic/Center |
| Location | 101 W 2nd St, Russellville, Kentucky |
| Authorized Official Name and Position | Latisha Edmonds (OFFICE ADMINISTRATOR) |
| Authorized Official Contact | 2702652574 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Southern Kentucky Primary Care, P.s.c. 1739 Canton St Hopkinsville KY 42240-1991 Ph: (270) 881-1813 | Southern Kentucky Primary Care, P.s.c. 101 W 2nd St Russellville KY 42276 Ph: (270) 881-1813 |
| NPI Number | 1003327412 |
|---|---|
| Provider Enumeration Date | 10/12/2017 |
| Last Update Date | 06/15/2018 |
| Medicare PECOS PAC ID | 7012274319 |
|---|---|
| Medicare Enrollment ID | O20171121002602 |
News Archive
Osteoarthritis (OA), the most common joint disorder throughout the world and a leading cause of disability, is characterized by pain, impaired joint mobility, reduction of muscular strength and loss of joint function. Unlike most other common diseases, little is known about its origins, and factors predicting a severe disease course have not been identified.
Royal Philips (NYSE: PHG, AEX: PHIA) today commented on a recent report of Cancer Research UK (CRUK), which indicates that innovations, such as digital pathology, image measurement and digital collaboration are recommended to avert major gaps in UK pathology services in the near future.
Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell transplantation will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
Biogen Idec and Knopp Neurosciences today announced they have entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize KNS-760704 (dexpramipexole) for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and potentially other indications.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003327412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Kentucky) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Osteoarthritis (OA), the most common joint disorder throughout the world and a leading cause of disability, is characterized by pain, impaired joint mobility, reduction of muscular strength and loss of joint function. Unlike most other common diseases, little is known about its origins, and factors predicting a severe disease course have not been identified.
Royal Philips (NYSE: PHG, AEX: PHIA) today commented on a recent report of Cancer Research UK (CRUK), which indicates that innovations, such as digital pathology, image measurement and digital collaboration are recommended to avert major gaps in UK pathology services in the near future.
Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell transplantation will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
Biogen Idec and Knopp Neurosciences today announced they have entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize KNS-760704 (dexpramipexole) for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and potentially other indications.
› Verified 9 days ago
Great Physician Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 975 Hopkinsville Rd, Russellville, KY 42276 Phone: 270-726-9568 Fax: 270-726-9570 | |
Logan Primary Care - Russellville Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 975 Hopkinsville Rd, Russellville, KY 42276 Phone: 270-726-2738 Fax: 270-726-9508 | |
Singh Medical Associates, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1405 Nashville St, Russellville, KY 42276 Phone: 270-725-9700 Fax: 270-725-9992 | |
Logan Family Practice Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1719 Nashville St, Russellville, KY 42276 Phone: 270-726-7664 | |
Community Health Centers Of Western Kentucky Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1497 Nashville Road, Russellville, KY 42276 Phone: 270-726-1266 Fax: 270-726-1961 | |
Lawrence Joseph Gotts Do Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1621 S Nashville St, Suite 104, Russellville, KY 42276 Phone: 270-726-4444 Fax: 270-726-4400 |